BCL2 and colorectal carcinoma: The anti-apoptotic protein BCL-2 was also upregulated in the resistant cells, while the pro-apoptotic BAX and cleaved caspase-3 were downregulated, thus PVT1 inhibits the intrinsic apoptotic pathway in cisplatin resistant CRC cells [262].